Enhancement of the serotonin-mediated acetylcholine release by repeated desmethylimipramine treatment in the hippocampus of freely moving rats

Takeshi Fujii, Shigeru Ohba, Katsuhiko Nakai, Kazuko Fujimoto, Takeshi Suzuki, Koichiro Kawashima

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A possible involvement of serotonin-mediated cholinergic activation in the antidepressant effect of desmethylimipramine (DMI) was investigated by determination of the effects of a single or repeated DMI administration on acetylcholine (ACh) release in the hippocampus using an in vivo microdialysis technique and a radioimmunoassay for ACh. Rats were administered DMI (10 mg/kg, i.p.) acutely or repeatedly for 21 days. A single or repeated DMI administration did not cause any significant effects on the basal ACh release compared with the respective controls. Atropine perfusion in the acutely DMI-treated or control rats increased the ACh release to the same degree. In repeatedly DMI-treated rats, serotonin (5-HT) (1 to 10 μM) perfusion enhanced significantly the ACh release. However, 5-HT in acutely DMI-treated rats enhanced significantly the ACh release only at 10 μM. 5-HT did not cause any changes in ACh release in control rats. Hippocampal 5-HT content of acutely DMI-treated rats was significantly higher than that of saline-treated control rats, while no difference was observed between the repeatedly DMI- and saline-treated rats. These findings suggest, for the first time, that DMI induced a facilitation of cholinergic neurotransmission in the rat hippocampus through the activation of 5-HT-receptor function.

Original languageEnglish
Pages (from-to)303-309
Number of pages7
JournalJapanese Journal of Pharmacology
Volume80
Issue number4
DOIs
Publication statusPublished - 1999

Fingerprint

Desipramine
Acetylcholine
Hippocampus
Serotonin
Cholinergic Agents
Perfusion
Serotonin Receptors
Microdialysis
Atropine
Synaptic Transmission
Antidepressive Agents
Radioimmunoassay

Keywords

  • Acetylcholine
  • Desmethylimipramine
  • Hippocampus
  • Microdialysis
  • Serotonin (5-HT)

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

Enhancement of the serotonin-mediated acetylcholine release by repeated desmethylimipramine treatment in the hippocampus of freely moving rats. / Fujii, Takeshi; Ohba, Shigeru; Nakai, Katsuhiko; Fujimoto, Kazuko; Suzuki, Takeshi; Kawashima, Koichiro.

In: Japanese Journal of Pharmacology, Vol. 80, No. 4, 1999, p. 303-309.

Research output: Contribution to journalArticle

@article{c29e649eaeca48479b14e7e786887715,
title = "Enhancement of the serotonin-mediated acetylcholine release by repeated desmethylimipramine treatment in the hippocampus of freely moving rats",
abstract = "A possible involvement of serotonin-mediated cholinergic activation in the antidepressant effect of desmethylimipramine (DMI) was investigated by determination of the effects of a single or repeated DMI administration on acetylcholine (ACh) release in the hippocampus using an in vivo microdialysis technique and a radioimmunoassay for ACh. Rats were administered DMI (10 mg/kg, i.p.) acutely or repeatedly for 21 days. A single or repeated DMI administration did not cause any significant effects on the basal ACh release compared with the respective controls. Atropine perfusion in the acutely DMI-treated or control rats increased the ACh release to the same degree. In repeatedly DMI-treated rats, serotonin (5-HT) (1 to 10 μM) perfusion enhanced significantly the ACh release. However, 5-HT in acutely DMI-treated rats enhanced significantly the ACh release only at 10 μM. 5-HT did not cause any changes in ACh release in control rats. Hippocampal 5-HT content of acutely DMI-treated rats was significantly higher than that of saline-treated control rats, while no difference was observed between the repeatedly DMI- and saline-treated rats. These findings suggest, for the first time, that DMI induced a facilitation of cholinergic neurotransmission in the rat hippocampus through the activation of 5-HT-receptor function.",
keywords = "Acetylcholine, Desmethylimipramine, Hippocampus, Microdialysis, Serotonin (5-HT)",
author = "Takeshi Fujii and Shigeru Ohba and Katsuhiko Nakai and Kazuko Fujimoto and Takeshi Suzuki and Koichiro Kawashima",
year = "1999",
doi = "10.1254/jjp.80.303",
language = "English",
volume = "80",
pages = "303--309",
journal = "Japanese Journal of Pharmacology",
issn = "0021-5198",
publisher = "Japanese Pharmacological Society",
number = "4",

}

TY - JOUR

T1 - Enhancement of the serotonin-mediated acetylcholine release by repeated desmethylimipramine treatment in the hippocampus of freely moving rats

AU - Fujii, Takeshi

AU - Ohba, Shigeru

AU - Nakai, Katsuhiko

AU - Fujimoto, Kazuko

AU - Suzuki, Takeshi

AU - Kawashima, Koichiro

PY - 1999

Y1 - 1999

N2 - A possible involvement of serotonin-mediated cholinergic activation in the antidepressant effect of desmethylimipramine (DMI) was investigated by determination of the effects of a single or repeated DMI administration on acetylcholine (ACh) release in the hippocampus using an in vivo microdialysis technique and a radioimmunoassay for ACh. Rats were administered DMI (10 mg/kg, i.p.) acutely or repeatedly for 21 days. A single or repeated DMI administration did not cause any significant effects on the basal ACh release compared with the respective controls. Atropine perfusion in the acutely DMI-treated or control rats increased the ACh release to the same degree. In repeatedly DMI-treated rats, serotonin (5-HT) (1 to 10 μM) perfusion enhanced significantly the ACh release. However, 5-HT in acutely DMI-treated rats enhanced significantly the ACh release only at 10 μM. 5-HT did not cause any changes in ACh release in control rats. Hippocampal 5-HT content of acutely DMI-treated rats was significantly higher than that of saline-treated control rats, while no difference was observed between the repeatedly DMI- and saline-treated rats. These findings suggest, for the first time, that DMI induced a facilitation of cholinergic neurotransmission in the rat hippocampus through the activation of 5-HT-receptor function.

AB - A possible involvement of serotonin-mediated cholinergic activation in the antidepressant effect of desmethylimipramine (DMI) was investigated by determination of the effects of a single or repeated DMI administration on acetylcholine (ACh) release in the hippocampus using an in vivo microdialysis technique and a radioimmunoassay for ACh. Rats were administered DMI (10 mg/kg, i.p.) acutely or repeatedly for 21 days. A single or repeated DMI administration did not cause any significant effects on the basal ACh release compared with the respective controls. Atropine perfusion in the acutely DMI-treated or control rats increased the ACh release to the same degree. In repeatedly DMI-treated rats, serotonin (5-HT) (1 to 10 μM) perfusion enhanced significantly the ACh release. However, 5-HT in acutely DMI-treated rats enhanced significantly the ACh release only at 10 μM. 5-HT did not cause any changes in ACh release in control rats. Hippocampal 5-HT content of acutely DMI-treated rats was significantly higher than that of saline-treated control rats, while no difference was observed between the repeatedly DMI- and saline-treated rats. These findings suggest, for the first time, that DMI induced a facilitation of cholinergic neurotransmission in the rat hippocampus through the activation of 5-HT-receptor function.

KW - Acetylcholine

KW - Desmethylimipramine

KW - Hippocampus

KW - Microdialysis

KW - Serotonin (5-HT)

UR - http://www.scopus.com/inward/record.url?scp=0032859235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032859235&partnerID=8YFLogxK

U2 - 10.1254/jjp.80.303

DO - 10.1254/jjp.80.303

M3 - Article

C2 - 10496330

AN - SCOPUS:0032859235

VL - 80

SP - 303

EP - 309

JO - Japanese Journal of Pharmacology

JF - Japanese Journal of Pharmacology

SN - 0021-5198

IS - 4

ER -